InvestorsHub Logo
Followers 1322
Posts 247420
Boards Moderated 55
Alias Born 12/07/2009

Re: None

Friday, 11/30/2018 10:23:04 AM

Friday, November 30, 2018 10:23:04 AM

Post# of 5582
IVST owns 20% of StemVax Therapeutics which is the first company in its Biotech Division. StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. Lead by world-renowned neuroscientist, Dr. Dwain Morris-Irvin, the Biotech & Health Sciences Division is currently focused on commercializing StemVax’s cancer vaccination therapy technology. https://www.otcivst.com/ $IVST


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.